Itriglumide (CR 2945) is an anthranilic acid derivative. Itriglumide is a potent and selective CCKB receptor antagonist, with an IC50 of 2.3 nM. Itriglumide antagonizes the response to gastrin in a dose-dependent manner with an IC50 of 5.9 nM. Itriglumide shows antisecretory and antiulcer activity[1].
Molecular Weight:
526.67
CAS Number:
[201605-51-8]
Formula:
C33H38N2O4
Target:
Cholecystokinin Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted